氧化诱导的过渡性缺血性发作 (TIA):一种罕见的呈现形式
Vikas K Jagtap1, Baiakmenlang Synmon2, Deiwakor Chyrmang1
1Department of Radiation Oncology, NEIGRIHMS, Shillong, Meghalaya, India.
Journal of cancer research and therapeutics
|October 16, 2024
概括
奥克萨利普拉丁可以引起罕见的神经副作用. 本案例研究详细介绍了一次过渡性缺血性发作 (TIA) 类事件,该事件发生在第二剂氧沙利普拉丁后,突出显示神经毒性的延迟发作.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 奥克沙利是结直肠癌的基石化疗剂.
- 与氧沙相关的神经不良事件已被记录,但通常在治疗早期表现出来.
- 报告的神经系统副作用包括黄斑,中风和神经.
研究的目的:
- 报告一种罕见的过渡性缺血性发作 (TIA) 类的神经副作用的情况,该副作用是由于施用了氧沙.
- 为了突出延迟发作的oxaliplatin诱导的神经毒性的潜力.
- 为了解oxaliplatin神经系统不良事件的范围做出贡献.
主要方法:
- 一名因结直肠恶性瘤而接受氧沙丁治疗的患者的病例报告.
- 详细的临床观察和神经症状的记录.
- 审查现有的关于oxaliplatin诱导的神经毒性的文献.
主要成果:
- 患者在接受第二剂氧沙后出现过渡性缺血性发作 (TIA) 类症状.
- 这种表现不寻常,因为此类事件通常在第一剂后立即报告.
- 神经学副作用是短暂的,这表明一种可逆的机制.
结论:
- 类似过渡性缺血性攻击 (TIA) 的事件可以作为oxaliplatin罕见的神经副作用发生.
- 这些副作用的发作可能会延迟,发生在第二剂后,而不是第一剂后.
- 在oxaliplatin治疗期间,临床医生应保持对神经毒性的高怀疑指数,即使出现延迟,也应保持.
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
179
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
179
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
2
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
2